Jim Cramer Likes Micron And Its CEO, Recommends Buying This Big Bank
Portfolio Pulse from Avi Kapoor
Jim Cramer recommends buying Micron and Bank of America, citing leadership and company performance. Baird upgraded Micron, while Bank of America faced a mini-tender offer rejection. Cramer advises selling JFrog amidst strong Q1 results. He's unimpressed with Biogen despite its earnings beat and does not favor Fidelis Insurance despite its positive earnings. Chevron is a buy, with Truist Securities raising its price target. Stock movements include declines for Biogen, Micron, Fidelis Insurance, and JFrog, with gains for Bank of America and Chevron.
May 13, 2024 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Bank of America recommended by Jim Cramer and faced a mini-tender offer rejection, with a slight stock price increase.
Cramer's recommendation and the rejection of a mini-tender offer may boost investor confidence, contributing to the stock's slight gain.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Chevron is a buy according to Cramer, with Truist Securities raising its price target and a slight stock increase.
Cramer's recommendation and Truist's price target raise suggest a bullish outlook, mirrored by the stock's modest gain.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 85
POSITIVE IMPACT
Micron recommended by Jim Cramer and upgraded by Baird, indicating positive sentiment despite recent stock price decline.
Cramer's endorsement and Baird's upgrade suggest strong confidence in Micron's future, potentially outweighing the recent price drop.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Biogen's actions not impressing Cramer despite an earnings beat, with a minor stock decline.
Despite outperforming earnings expectations, Cramer's lack of enthusiasm and a slight stock decline suggest caution.
CONFIDENCE 65
IMPORTANCE 70
RELEVANCE 75
NEGATIVE IMPACT
Fidelis Insurance not favored by Cramer despite positive earnings, experiencing a stock price drop.
Cramer's disfavor, despite better-than-expected earnings, may influence investor sentiment, contributing to the stock's decline.
CONFIDENCE 60
IMPORTANCE 65
RELEVANCE 70
NEGATIVE IMPACT
JFrog advised as a sell by Cramer despite strong Q1 results, with a significant stock price drop.
Cramer's sell recommendation contrasts with strong Q1 results, but the significant stock drop indicates market agreement.
CONFIDENCE 70
IMPORTANCE 80
RELEVANCE 80